Updated daily · Free
Research Jobs Board
PhD, postdoc & biotech industry positions — aggregated daily.
🔔 Get these jobs by email
We’ll email you new matches for all research jobs. Free, unsubscribe anytime.
✅ Alert created!
675 jobs
1 week, 4 days ago · via Greenhouse/generatebiomedicines
Scientist I / Scientist II, Computational Protein Design
The Role: We are seeking a creative, motivated Computational Protein Design Scientist to join our Model-Driven Design team at Generate:Biomedicines . You will join a talented and collaborative group of ML scientists, engineers, and wet-lab scientists dedicated to redefining how medicines are made. This role sits at the intersection of machine learning, structural biology, and therapeutic development, where you will stay at the leading edge of internal and external models for de novo protein desi
2 days, 19 hours ago · via Greenhouse/valencelabs
Research Scientist, Next-Generation Structural Biology & Atomistic Modeling
About Valence Labs Valence Labs is Recursion’s frontier AI research engine. We lead high-impact research programs designed to materially expand Recursion’s ability to discover and develop medicines for complex diseases. Our team balances near-term pragmatism with a long-term view of where the field is heading in the next 3–5 years, incubating, designing, and productizing the approaches we believe will define the future of drug discovery. Our work is driven by optimism, purpose, and a shared visi
4 days, 8 hours ago · via jobRxiv
Principal Scientist GMP Microbiology Lilly Medicine Foundry
Principal Scientist, GMP QC Microbiology At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve.
3 days, 13 hours ago · via jobRxiv
Postdoctoral Fellow in Cancer Research
A Postdoctoral Fellow position is available in Dr. Yi Huang’s lab in the Department of Internal Medicine and the Holden Comprehensive Cancer Center at the Carver College of Medicine, University of Iowa. This position will focus on the epigenetic roles of histone modifications in breast cancer development and therapeutic response, with the goal of uncovering novel mechanisms that drive tumorigenesis and contribute to therapeutic resistance. Dr. Huang’s lab is NIH-funded and has extensive expertis
4 days, 11 hours ago · via Greenhouse/revolutionmedicines
Director, Target Biology
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G
4 days, 11 hours ago · via Greenhouse/revolutionmedicines
Scientist II, Assay Operations, Screening Platform Technologies
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G
4 days, 11 hours ago · via Greenhouse/revolutionmedicines
Senior Scientist II, DMPK
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G
4 days, 11 hours ago · via Greenhouse/natera
Bioinformatics Manager (Oncology Product Development)
Natera is currently seeking a Bioinformatics Manager to join the Bioinformatics team focused on Oncology Product Development. In this role, the individual will manage a team of Bioinformaticians and Data Scientists and provide technical leadership in the design, development and validation of ctDNA-based diagnostic tests. This position requires extensive cross-functional collaboration with biostatistics, molecular biology, software engineering and commercial departments. The ideal candidate will
1 week, 2 days ago · via jobRxiv
Scientist – CRISPR Screening, target identification
Scientist Position We are seeking a highly qualified scientist to join the Oncology & Immuno-Oncology group. The successful candidate will support the identification and validation of novel tumor drug targets using in vitro and in vivo approaches. The ideal applicant is motivated, organized, detail-oriented, and effective in a fast-paced, team-driven environment. Strong communication skills are essential. Experience with murine tumor models, mammalian cell culture, and molecular or cell-bas
2 days, 19 hours ago · via Greenhouse/recursionpharmaceuticals
Associate Director, Computational Biology – Early Discovery
Your work will change lives. Including your own. The Impact You’ll Make As an Associate Director within Recursion’s early discovery team, you will be at the forefront of reimagining drug discovery from first principles. You will lead a team of world-class computational biologists focused on identifying and advancing the next generation of oncology targets and therapeutics to fill our internal pipeline. You will act as a "player-coach," balancing direct technical contribution with the mentorship
5 days, 1 hour ago · via jobRxiv
Scientist / Senior Scientist, Structural Biology
Join Amgen's Mission of Serving Patients At Amgen, if you feel like you're part of something bigger, it's because you are. Our shared mission—to serve patients living with serious illnesses—drives all that we do. Since 1980, we've helped pioneer the world of biotech in our fight against the world's toughest diseases. With our focus on four therapeutic areas –Oncology, Inflammation, General Medicine, and Rare Disease– we reach millions of patients each year. Amgen is adva
4 days, 11 hours ago · via Greenhouse/revolutionmedicines
Associate Scientist, Research Laboratory Operations
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G
Jobs aggregated daily from Greenhouse boards, Science Careers RSS, and Adzuna. Each link opens the original posting.